 |
Recombinant retroviral vector – glucocerebrosidase |
|---|---|
| Trade Name | |
| Orphan Indication | For use as enzyme replacement therapy for patients with types I, II, or III Gaucher disease |
| USA Market Approval | USA |
| USA Designation Date | 1993-11-15 00:00:00 |
| Sponsor | Genetic Therapy, Inc.;938 Clopper Road;Gaithersburg, Maryland, 20878 |
